Goal: To evaluate the impact of the Ross operation, recently (1997) introdu
ced in our unit, for the treatment of patients with congenital aortic valve
stenosis.
Methods: The period from January 1997 to December 2000 was compared with th
e previous 5 years (1992-96). Thirty-seven children (<16 yrs) and 49 young
adults (16-50 yrs) with congenital aortic valve stenosis underwent one of t
hese treatments: percutaneous balloon dilatation (PBD), aortic valve commis
surotomy, aortic valve replacement and the Ross operation. The Ross operati
on was performed in 16 patients, mean age 24.5 yrs (range 9-46 yrs) with a
bicuspid stenotic aortic valve, 7/10 adults with calcifications, 2/10 adult
s with previous aortic valve commissurotomy, 4/6 children with aortic regur
gitation following PBD, and 1/6 children who had had a previous aortic valv
e replacement with a prosthetic valve and aortic root enlargement.
Results: PBD was followed by death in two neonates (fibroelastosis); all ot
her children survived PBD. Although there were no deaths, PBD in adults was
recently abandoned, owing to unfavourable results. Aortic valve commissuro
tomy showed good results in children (no deaths). Aortic valve replacement,
although associated with good results (no deaths), has been recently aband
oned in children in favour of the Ross operation. Over a mean follow-up of
16 months (2-40 months) all patients are asymptomatic following Ross operat
ion, with no echocardiographic evidence of aortic valve regurgitation in 10
/16 patients and with trivial regurgitation in 6/16 patients.
Conclusions: The approach now for children and young adults with congenital
aortic valve stenosis should be as follows: (1) PBD is the first choice in
neonates and infants; (2) Aortic valve commissurotomy is the first choice
for children, neonates and infants after failed PBD; (3) The Ross operation
is increasingly used in children after failed PBD and in young adults, eve
n with a calcified aortic valve.